Global Amniotic Membrane

Amniotic Membrane Comprehensive Study by Application (Surgical Wounds, Ophthalmology, Others), Enzyme (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane), End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers and Laboratory) Players and Region - Global Market Outlook to 2028

Amniotic Membrane Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 9.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The amniotic membrane is defined as the innermost layer of the placenta with a thickness of 0.02-0.05 mm. It is used in two categories namely the management of wounds as well as a biological bandage for the treatment. It is widely used in the treatment of various diseases such as eye surface disorders, corneal degeneration, ocular dystrophy, eyelid reconstruction, bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, among others. Demand for amniotic membrane has increased, due to the rising number of non-communicable diseases patients. For instance, 1n 2018, as per an article published by the World Health Organization (WHO), non-communicable diseases, such as Cardiovascular Diseases chronic respiratory diseases, diabetes, as well as cancer together account for more than 86% of deaths and also it is found that more than 77% of the disease burden in the European region. Therefore, increasing the prevalence of chronic diseases will affect the growth of the market in the future. According to AMA Research, the market for Amniotic Membrane is expected to register a CAGR of 9.9% during the forecast period to 2028. This growth is primarily driven by Growing Research and Development Investments in the Field Of Stem Cell & Regenerative Medicine .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitM Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Facilities sector in the Asia Pacific region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as FzioMed, Inc. (United States), Skye Biologics Inc. (United States), IOP Ophthalmics (United States), Amniox Medical, Inc. (United States), Amnio Technology, LLC (United States), Applied Biologics LLC (United States), Alliqua BioMedical, Inc. (United States), Human Regenerative Technologies LLC (United States), Derma Sciences Inc. (United States) and MiMedx Group, Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2022, Amnio Technology has launched two new PallinGen membrane products: PalinGen X Membrane and Dual Layer PallinGen X Membrane. This membrane is indicated for patients suffering from acute and chronic wounds that do not heal, as well as complex or open surgical wounds. and In 2021, Audax Private Equity announced the successful completion of the sale of Katena products to Corza Medical. Corza Medical is a GTCR portfolio company. Katena is a renowned provider of ophthalmic devices and therapeutics to hospitals, surgical centers and clinics.
In 2022, Merakris Therapeutics has launched the Dermacyte Matrix. Amniotic membrane used to protect and repair damaged tissue., In 2022, TissueTech, renowned for the clinical application of cryopreserved human birth tissue products to treat chronic wounds, ocular surface disorders and musculoskeletal disorders, has unveiled a new name and new logo. BioTissue, Inc. and Amniox Medical, Inc. will all become known as a single entity, BioTissue, Inc. and In February 2019, the Israeli doctors (Rambam Health Care Campus) has recently conducted a successful procedure. In this procedure, where a woman’s eyesight has been restored using the placenta. Hence, it will affect the growth of the market in the future.Amniotic Membrane market is a fragmented market due to the presence of various players. Companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Influencing Trend:
Technology Advancements regarding Amniotic Membrane

Market Growth Drivers:
Growing Research and Development Investments in the Field Of Stem Cell & Regenerative Medicine and Increase in the Number of Surgeries Being Performed across the World

Challenges:
Lack of Awareness in Some Region

Restraints:
Stringent Rules as well as Regulation

Opportunities:
Government Initiative Regarding the Treatment of Diseases and Growing Demand from Emerging Economics such as China, India, among others

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Amniotic Membrane Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Amniotic Membrane Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Amniotic Membrane players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Amniotic Membrane Study Sheds Light on
— The Amniotic Membrane Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Amniotic Membrane industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Amniotic Membrane industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Surgical Wounds
  • Ophthalmology
  • Others
By Enzyme
  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers and Laboratory

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Research and Development Investments in the Field Of Stem Cell & Regenerative Medicine
      • 3.2.2. Increase in the Number of Surgeries Being Performed across the World
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in Some Region
    • 3.4. Market Trends
      • 3.4.1. Technology Advancements regarding Amniotic Membrane
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Amniotic Membrane, by Application, Enzyme , End User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Amniotic Membrane (Value)
      • 5.2.1. Global Amniotic Membrane by: Application (Value)
        • 5.2.1.1. Surgical Wounds
        • 5.2.1.2. Ophthalmology
        • 5.2.1.3. Others
      • 5.2.2. Global Amniotic Membrane by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Specialized Clinics
        • 5.2.2.4. Research Centers and Laboratory
      • 5.2.3. Global Amniotic Membrane Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Amniotic Membrane (Volume)
      • 5.3.1. Global Amniotic Membrane by: Application (Volume)
        • 5.3.1.1. Surgical Wounds
        • 5.3.1.2. Ophthalmology
        • 5.3.1.3. Others
      • 5.3.2. Global Amniotic Membrane by: End User (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Ambulatory Surgical Centers
        • 5.3.2.3. Specialized Clinics
        • 5.3.2.4. Research Centers and Laboratory
      • 5.3.3. Global Amniotic Membrane Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Amniotic Membrane (Price)
  • 6. Amniotic Membrane: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. FzioMed, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Skye Biologics Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. IOP Ophthalmics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Amniox Medical, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Amnio Technology, LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Applied Biologics LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Alliqua BioMedical, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Human Regenerative Technologies LLC (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Derma Sciences Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MiMedx Group, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Amniotic Membrane Sale, by Application, Enzyme , End User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Amniotic Membrane (Value)
      • 7.2.1. Global Amniotic Membrane by: Application (Value)
        • 7.2.1.1. Surgical Wounds
        • 7.2.1.2. Ophthalmology
        • 7.2.1.3. Others
      • 7.2.2. Global Amniotic Membrane by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Specialized Clinics
        • 7.2.2.4. Research Centers and Laboratory
      • 7.2.3. Global Amniotic Membrane Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Amniotic Membrane (Volume)
      • 7.3.1. Global Amniotic Membrane by: Application (Volume)
        • 7.3.1.1. Surgical Wounds
        • 7.3.1.2. Ophthalmology
        • 7.3.1.3. Others
      • 7.3.2. Global Amniotic Membrane by: End User (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Ambulatory Surgical Centers
        • 7.3.2.3. Specialized Clinics
        • 7.3.2.4. Research Centers and Laboratory
      • 7.3.3. Global Amniotic Membrane Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Amniotic Membrane (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Amniotic Membrane: by Application(USD Million)
  • Table 2. Amniotic Membrane Surgical Wounds , by Region USD Million (2017-2022)
  • Table 3. Amniotic Membrane Ophthalmology , by Region USD Million (2017-2022)
  • Table 4. Amniotic Membrane Others , by Region USD Million (2017-2022)
  • Table 5. Amniotic Membrane: by End User(USD Million)
  • Table 6. Amniotic Membrane Hospitals , by Region USD Million (2017-2022)
  • Table 7. Amniotic Membrane Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 8. Amniotic Membrane Specialized Clinics , by Region USD Million (2017-2022)
  • Table 9. Amniotic Membrane Research Centers and Laboratory , by Region USD Million (2017-2022)
  • Table 10. South America Amniotic Membrane, by Country USD Million (2017-2022)
  • Table 11. South America Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 12. South America Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 13. South America Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 14. Brazil Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 15. Brazil Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 16. Brazil Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 17. Argentina Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 18. Argentina Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 19. Argentina Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 20. Rest of South America Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 21. Rest of South America Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 22. Rest of South America Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 23. Asia Pacific Amniotic Membrane, by Country USD Million (2017-2022)
  • Table 24. Asia Pacific Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 25. Asia Pacific Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 26. Asia Pacific Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 27. China Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 28. China Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 29. China Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 30. Japan Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 31. Japan Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 32. Japan Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 33. India Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 34. India Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 35. India Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 36. South Korea Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 37. South Korea Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 38. South Korea Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 39. Taiwan Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 40. Taiwan Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 41. Taiwan Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 42. Australia Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 43. Australia Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 44. Australia Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 45. Rest of Asia-Pacific Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 46. Rest of Asia-Pacific Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 48. Europe Amniotic Membrane, by Country USD Million (2017-2022)
  • Table 49. Europe Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 50. Europe Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 51. Europe Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 52. Germany Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 53. Germany Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 54. Germany Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 55. France Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 56. France Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 57. France Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 58. Italy Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 59. Italy Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 60. Italy Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 61. United Kingdom Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 62. United Kingdom Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 63. United Kingdom Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 64. Netherlands Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 65. Netherlands Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 66. Netherlands Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 67. Rest of Europe Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 68. Rest of Europe Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 69. Rest of Europe Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 70. MEA Amniotic Membrane, by Country USD Million (2017-2022)
  • Table 71. MEA Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 72. MEA Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 73. MEA Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 74. Middle East Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 75. Middle East Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 76. Middle East Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 77. Africa Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 78. Africa Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 79. Africa Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 80. North America Amniotic Membrane, by Country USD Million (2017-2022)
  • Table 81. North America Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 82. North America Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 83. North America Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 84. United States Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 85. United States Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 86. United States Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 87. Canada Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 88. Canada Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 89. Canada Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 90. Mexico Amniotic Membrane, by Application USD Million (2017-2022)
  • Table 91. Mexico Amniotic Membrane, by Enzyme USD Million (2017-2022)
  • Table 92. Mexico Amniotic Membrane, by End User USD Million (2017-2022)
  • Table 93. Amniotic Membrane Sales: by Application(M Units)
  • Table 94. Amniotic Membrane Sales Surgical Wounds , by Region M Units (2017-2022)
  • Table 95. Amniotic Membrane Sales Ophthalmology , by Region M Units (2017-2022)
  • Table 96. Amniotic Membrane Sales Others , by Region M Units (2017-2022)
  • Table 97. Amniotic Membrane Sales: by End User(M Units)
  • Table 98. Amniotic Membrane Sales Hospitals , by Region M Units (2017-2022)
  • Table 99. Amniotic Membrane Sales Ambulatory Surgical Centers , by Region M Units (2017-2022)
  • Table 100. Amniotic Membrane Sales Specialized Clinics , by Region M Units (2017-2022)
  • Table 101. Amniotic Membrane Sales Research Centers and Laboratory , by Region M Units (2017-2022)
  • Table 102. South America Amniotic Membrane Sales, by Country M Units (2017-2022)
  • Table 103. South America Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 104. South America Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 105. South America Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 106. Brazil Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 107. Brazil Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 108. Brazil Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 109. Argentina Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 110. Argentina Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 111. Argentina Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 112. Rest of South America Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 113. Rest of South America Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 114. Rest of South America Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 115. Asia Pacific Amniotic Membrane Sales, by Country M Units (2017-2022)
  • Table 116. Asia Pacific Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 117. Asia Pacific Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 118. Asia Pacific Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 119. China Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 120. China Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 121. China Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 122. Japan Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 123. Japan Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 124. Japan Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 125. India Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 126. India Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 127. India Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 128. South Korea Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 129. South Korea Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 130. South Korea Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 131. Taiwan Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 132. Taiwan Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 133. Taiwan Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 134. Australia Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 135. Australia Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 136. Australia Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 137. Rest of Asia-Pacific Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 138. Rest of Asia-Pacific Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 139. Rest of Asia-Pacific Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 140. Europe Amniotic Membrane Sales, by Country M Units (2017-2022)
  • Table 141. Europe Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 142. Europe Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 143. Europe Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 144. Germany Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 145. Germany Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 146. Germany Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 147. France Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 148. France Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 149. France Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 150. Italy Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 151. Italy Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 152. Italy Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 153. United Kingdom Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 154. United Kingdom Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 155. United Kingdom Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 156. Netherlands Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 157. Netherlands Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 158. Netherlands Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 159. Rest of Europe Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 160. Rest of Europe Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 161. Rest of Europe Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 162. MEA Amniotic Membrane Sales, by Country M Units (2017-2022)
  • Table 163. MEA Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 164. MEA Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 165. MEA Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 166. Middle East Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 167. Middle East Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 168. Middle East Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 169. Africa Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 170. Africa Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 171. Africa Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 172. North America Amniotic Membrane Sales, by Country M Units (2017-2022)
  • Table 173. North America Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 174. North America Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 175. North America Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 176. United States Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 177. United States Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 178. United States Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 179. Canada Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 180. Canada Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 181. Canada Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 182. Mexico Amniotic Membrane Sales, by Application M Units (2017-2022)
  • Table 183. Mexico Amniotic Membrane Sales, by Enzyme M Units (2017-2022)
  • Table 184. Mexico Amniotic Membrane Sales, by End User M Units (2017-2022)
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Amniotic Membrane: by Application(USD Million)
  • Table 196. Amniotic Membrane Surgical Wounds , by Region USD Million (2023-2028)
  • Table 197. Amniotic Membrane Ophthalmology , by Region USD Million (2023-2028)
  • Table 198. Amniotic Membrane Others , by Region USD Million (2023-2028)
  • Table 199. Amniotic Membrane: by End User(USD Million)
  • Table 200. Amniotic Membrane Hospitals , by Region USD Million (2023-2028)
  • Table 201. Amniotic Membrane Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 202. Amniotic Membrane Specialized Clinics , by Region USD Million (2023-2028)
  • Table 203. Amniotic Membrane Research Centers and Laboratory , by Region USD Million (2023-2028)
  • Table 204. South America Amniotic Membrane, by Country USD Million (2023-2028)
  • Table 205. South America Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 206. South America Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 207. South America Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 208. Brazil Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 209. Brazil Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 210. Brazil Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 211. Argentina Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 212. Argentina Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 213. Argentina Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 214. Rest of South America Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 215. Rest of South America Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 216. Rest of South America Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 217. Asia Pacific Amniotic Membrane, by Country USD Million (2023-2028)
  • Table 218. Asia Pacific Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 219. Asia Pacific Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 220. Asia Pacific Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 221. China Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 222. China Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 223. China Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 224. Japan Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 225. Japan Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 226. Japan Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 227. India Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 228. India Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 229. India Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 230. South Korea Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 231. South Korea Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 232. South Korea Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 233. Taiwan Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 234. Taiwan Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 235. Taiwan Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 236. Australia Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 237. Australia Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 238. Australia Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 239. Rest of Asia-Pacific Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 240. Rest of Asia-Pacific Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 241. Rest of Asia-Pacific Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 242. Europe Amniotic Membrane, by Country USD Million (2023-2028)
  • Table 243. Europe Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 244. Europe Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 245. Europe Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 246. Germany Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 247. Germany Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 248. Germany Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 249. France Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 250. France Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 251. France Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 252. Italy Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 253. Italy Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 254. Italy Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 255. United Kingdom Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 256. United Kingdom Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 257. United Kingdom Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 258. Netherlands Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 259. Netherlands Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 260. Netherlands Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 261. Rest of Europe Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 262. Rest of Europe Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 263. Rest of Europe Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 264. MEA Amniotic Membrane, by Country USD Million (2023-2028)
  • Table 265. MEA Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 266. MEA Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 267. MEA Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 268. Middle East Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 269. Middle East Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 270. Middle East Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 271. Africa Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 272. Africa Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 273. Africa Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 274. North America Amniotic Membrane, by Country USD Million (2023-2028)
  • Table 275. North America Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 276. North America Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 277. North America Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 278. United States Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 279. United States Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 280. United States Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 281. Canada Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 282. Canada Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 283. Canada Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 284. Mexico Amniotic Membrane, by Application USD Million (2023-2028)
  • Table 285. Mexico Amniotic Membrane, by Enzyme USD Million (2023-2028)
  • Table 286. Mexico Amniotic Membrane, by End User USD Million (2023-2028)
  • Table 287. Amniotic Membrane Sales: by Application(M Units)
  • Table 288. Amniotic Membrane Sales Surgical Wounds , by Region M Units (2023-2028)
  • Table 289. Amniotic Membrane Sales Ophthalmology , by Region M Units (2023-2028)
  • Table 290. Amniotic Membrane Sales Others , by Region M Units (2023-2028)
  • Table 291. Amniotic Membrane Sales: by End User(M Units)
  • Table 292. Amniotic Membrane Sales Hospitals , by Region M Units (2023-2028)
  • Table 293. Amniotic Membrane Sales Ambulatory Surgical Centers , by Region M Units (2023-2028)
  • Table 294. Amniotic Membrane Sales Specialized Clinics , by Region M Units (2023-2028)
  • Table 295. Amniotic Membrane Sales Research Centers and Laboratory , by Region M Units (2023-2028)
  • Table 296. South America Amniotic Membrane Sales, by Country M Units (2023-2028)
  • Table 297. South America Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 298. South America Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 299. South America Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 300. Brazil Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 301. Brazil Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 302. Brazil Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 303. Argentina Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 304. Argentina Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 305. Argentina Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 306. Rest of South America Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 307. Rest of South America Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 308. Rest of South America Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 309. Asia Pacific Amniotic Membrane Sales, by Country M Units (2023-2028)
  • Table 310. Asia Pacific Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 311. Asia Pacific Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 312. Asia Pacific Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 313. China Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 314. China Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 315. China Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 316. Japan Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 317. Japan Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 318. Japan Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 319. India Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 320. India Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 321. India Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 322. South Korea Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 323. South Korea Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 324. South Korea Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 325. Taiwan Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 326. Taiwan Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 327. Taiwan Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 328. Australia Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 329. Australia Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 330. Australia Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 331. Rest of Asia-Pacific Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 332. Rest of Asia-Pacific Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 333. Rest of Asia-Pacific Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 334. Europe Amniotic Membrane Sales, by Country M Units (2023-2028)
  • Table 335. Europe Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 336. Europe Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 337. Europe Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 338. Germany Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 339. Germany Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 340. Germany Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 341. France Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 342. France Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 343. France Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 344. Italy Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 345. Italy Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 346. Italy Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 347. United Kingdom Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 348. United Kingdom Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 349. United Kingdom Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 350. Netherlands Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 351. Netherlands Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 352. Netherlands Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 353. Rest of Europe Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 354. Rest of Europe Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 355. Rest of Europe Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 356. MEA Amniotic Membrane Sales, by Country M Units (2023-2028)
  • Table 357. MEA Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 358. MEA Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 359. MEA Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 360. Middle East Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 361. Middle East Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 362. Middle East Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 363. Africa Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 364. Africa Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 365. Africa Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 366. North America Amniotic Membrane Sales, by Country M Units (2023-2028)
  • Table 367. North America Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 368. North America Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 369. North America Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 370. United States Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 371. United States Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 372. United States Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 373. Canada Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 374. Canada Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 375. Canada Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 376. Mexico Amniotic Membrane Sales, by Application M Units (2023-2028)
  • Table 377. Mexico Amniotic Membrane Sales, by Enzyme M Units (2023-2028)
  • Table 378. Mexico Amniotic Membrane Sales, by End User M Units (2023-2028)
  • Table 379. Research Programs/Design for This Report
  • Table 380. Key Data Information from Secondary Sources
  • Table 381. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Amniotic Membrane: by Application USD Million (2017-2022)
  • Figure 5. Global Amniotic Membrane: by End User USD Million (2017-2022)
  • Figure 6. South America Amniotic Membrane Share (%), by Country
  • Figure 7. Asia Pacific Amniotic Membrane Share (%), by Country
  • Figure 8. Europe Amniotic Membrane Share (%), by Country
  • Figure 9. MEA Amniotic Membrane Share (%), by Country
  • Figure 10. North America Amniotic Membrane Share (%), by Country
  • Figure 11. Global Amniotic Membrane: by Application M Units (2017-2022)
  • Figure 12. Global Amniotic Membrane: by End User M Units (2017-2022)
  • Figure 13. South America Amniotic Membrane Share (%), by Country
  • Figure 14. Asia Pacific Amniotic Membrane Share (%), by Country
  • Figure 15. Europe Amniotic Membrane Share (%), by Country
  • Figure 16. MEA Amniotic Membrane Share (%), by Country
  • Figure 17. North America Amniotic Membrane Share (%), by Country
  • Figure 18. Global Amniotic Membrane share by Players 2022 (%)
  • Figure 19. Global Amniotic Membrane share by Players (Top 3) 2022(%)
  • Figure 20. Global Amniotic Membrane share by Players (Top 5) 2022(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. FzioMed, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. FzioMed, Inc. (United States) Revenue: by Geography 2022
  • Figure 24. Skye Biologics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Skye Biologics Inc. (United States) Revenue: by Geography 2022
  • Figure 26. IOP Ophthalmics (United States) Revenue, Net Income and Gross profit
  • Figure 27. IOP Ophthalmics (United States) Revenue: by Geography 2022
  • Figure 28. Amniox Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Amniox Medical, Inc. (United States) Revenue: by Geography 2022
  • Figure 30. Amnio Technology, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 31. Amnio Technology, LLC (United States) Revenue: by Geography 2022
  • Figure 32. Applied Biologics LLC (United States) Revenue, Net Income and Gross profit
  • Figure 33. Applied Biologics LLC (United States) Revenue: by Geography 2022
  • Figure 34. Alliqua BioMedical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Alliqua BioMedical, Inc. (United States) Revenue: by Geography 2022
  • Figure 36. Human Regenerative Technologies LLC (United States) Revenue, Net Income and Gross profit
  • Figure 37. Human Regenerative Technologies LLC (United States) Revenue: by Geography 2022
  • Figure 38. Derma Sciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Derma Sciences Inc. (United States) Revenue: by Geography 2022
  • Figure 40. MiMedx Group, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. MiMedx Group, Inc. (United States) Revenue: by Geography 2022
  • Figure 42. Global Amniotic Membrane: by Application USD Million (2023-2028)
  • Figure 43. Global Amniotic Membrane: by End User USD Million (2023-2028)
  • Figure 44. South America Amniotic Membrane Share (%), by Country
  • Figure 45. Asia Pacific Amniotic Membrane Share (%), by Country
  • Figure 46. Europe Amniotic Membrane Share (%), by Country
  • Figure 47. MEA Amniotic Membrane Share (%), by Country
  • Figure 48. North America Amniotic Membrane Share (%), by Country
  • Figure 49. Global Amniotic Membrane: by Application M Units (2023-2028)
  • Figure 50. Global Amniotic Membrane: by End User M Units (2023-2028)
  • Figure 51. South America Amniotic Membrane Share (%), by Country
  • Figure 52. Asia Pacific Amniotic Membrane Share (%), by Country
  • Figure 53. Europe Amniotic Membrane Share (%), by Country
  • Figure 54. MEA Amniotic Membrane Share (%), by Country
  • Figure 55. North America Amniotic Membrane Share (%), by Country
List of companies from research coverage that are profiled in the study
  • FzioMed, Inc. (United States)
  • Skye Biologics Inc. (United States)
  • IOP Ophthalmics (United States)
  • Amniox Medical, Inc. (United States)
  • Amnio Technology, LLC (United States)
  • Applied Biologics LLC (United States)
  • Alliqua BioMedical, Inc. (United States)
  • Human Regenerative Technologies LLC (United States)
  • Derma Sciences Inc. (United States)
  • MiMedx Group, Inc. (United States)
Additional players considered in the study are as follows:
Integra LifeSciences (United States) , Osiris Therapeutics, Inc. (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 161 Pages 67 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Amniotic Membrane Quantitative research analysis
Global Amniotic Membrane Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Amniotic Membrane Market are FzioMed, Inc. (United States), Skye Biologics Inc. (United States), IOP Ophthalmics (United States), Amniox Medical, Inc. (United States), Amnio Technology, LLC (United States), Applied Biologics LLC (United States), Alliqua BioMedical, Inc. (United States), Human Regenerative Technologies LLC (United States), Derma Sciences Inc. (United States) and MiMedx Group, Inc. (United States) etc.
Surgical Wounds segment in Global market to hold robust market share owing to "Growing Research and Development Investments in the Field Of Stem Cell & Regenerative Medicine ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Amniotic Membrane market throughout the forecasted period.

Know More About Global Amniotic Membrane Report?

Have a Query? Click Here

Other Related Reports

Lifestyle Drugs Comprehensive Study by Type (Depression, Dermatology, Sexual dysfunction, Obesity), Application (Children, Adults, Senior Citizens), Form (Tablets, External Use, Injection) Players an...
$ 3500
Cattle Health Comprehensive Study by Type (Vaccines, Pharmaceuticals (Parasiticides, Anti-infective, Anti-inflammatory, Analgesics, Others), Feed Additives (Nutritional, Medicinal ), Diagnostics), Ap...
$ 3650
Wound Dressing Comprehensive Study by Type (Advanced Wound Dressings, Traditional Wound Dressing), Application (Diabetic Foot Ulcers, Pressure Ulcers, Venous Ulcers, Surgical Wounds, Burns, Others), ...
$ 3750
Medical Scrub Caps Comprehensive Study by Type (Bouffant Scrub Cap, Integral, Close-Fitting, Others), Application (Operating Room, Clean Room, Pharmaceutical, Laboratory), Distribution Channel (Onlin...
$ 3650
Medical Air Conditioners Comprehensive Study by Application (Pharmacies, Clinics, Hospitals, Veterinary, Others), Mounting (Wall-Mounted, Ceiling-Mounted), Air Conditioner (Central Air Conditioning, ...
$ 3450
Home Health Care Providers Comprehensive Study by Type (Home Telehealth Monitoring Devices, Home Telehealth Services, Telehealth Software Solutions), Product (Testing, Screening, and Monitoring (Bloo...
$ 3750